Literature DB >> 27296824

Diagnostic challenges of bronchiectasis.

Guillermo Suarez-Cuartin1, James D Chalmers2, Oriol Sibila3.   

Abstract

Bronchiectasis is a condition of increasing incidence and prevalence around the world. Many different diseases have been associated with bronchiectasis, and their treatment can differ widely. Recent guidelines have helped to approach aetiological diagnosis but it is still a complex process. Identifying the cause of the bronchiectasis may determine a change in the treatment of a large group of subjects. That is one of the main reasons why the aetiological diagnosis is crucial in the proper management of bronchiectasis patients. Postinfectious bronchiectasis is the most frequent entity among different studies, but a high percentage of cases still remain without a clear aetiology. Bronchiectasis related to allergic bronchopulmonary aspergillosis (ABPA), immunodeficiencies with antibody production deficiency, primary ciliary dyskinesia, cystic fibrosis and alpha-1-antitrypsin deficiency, among others, require a specific management that may improve quality of life and prognosis in a large group of individuals. Therefore, the aim of this article is to review the main bronchiectasis related diseases and to simplify the aetiological diagnosis, in order to improve the management of bronchiectasis patients, especially in those where a specific treatment is available.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27296824     DOI: 10.1016/j.rmed.2016.05.014

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

Review 1.  The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation.

Authors:  Koshika Yadava; Paul Bollyky; Melissa A Lawson
Journal:  Immunology       Date:  2016-08-16       Impact factor: 7.397

2.  Chronic rhinosinusitis is associated with higher prevalence and severity of bronchiectasis in patients with COPD.

Authors:  Xia Yang; Yali Xu; Jianmin Jin; Ruimin Li; Xiaofang Liu; Yongchang Sun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-02-20

3.  Viruses in bronchiectasis: a pilot study to explore the presence of community acquired respiratory viruses in stable patients and during acute exacerbations.

Authors:  Alicia B Mitchell; Bassel Mourad; Lachlan Buddle; Matthew J Peters; Brian G G Oliver; Lucy C Morgan
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

4.  Post-infective bronchiectasis by measles prior infection - A case report.

Authors:  Maria Braz; Ana Cristina Ferreira; Ana Sofia Sousa; Fernando Barata
Journal:  Respir Med Case Rep       Date:  2019-01-18

Review 5.  The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.

Authors:  James D Chalmers; Megan Crichton; Pieter C Goeminne; Michael R Loebinger; Charles Haworth; Marta Almagro; Montse Vendrell; Anthony De Soyza; Raja Dhar; Lucy Morgan; Francesco Blasi; Stefano Aliberti; Jeanette Boyd; Eva Polverino
Journal:  Breathe (Sheff)       Date:  2017-09

Review 6.  Patient participation in ERS guidelines and research projects: the EMBARC experience.

Authors:  James D Chalmers; Alan Timothy; Eva Polverino; Marta Almagro; Thomas Ruddy; Pippa Powell; Jeanette Boyd
Journal:  Breathe (Sheff)       Date:  2017-09

7.  Profile of Clinical and Analytical Parameters in Bronchiectasis Patients during the COVID-19 Pandemic: A One-Year Follow-Up Pilot Study.

Authors:  Liyun Qin; Filipe Gonçalves-Carvalho; Yingchen Xia; Jianhua Zha; Mireia Admetlló; José María Maiques; Sandra Esteban-Cucó; Xavier Duran; Alicia Marín; Esther Barreiro
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.